medigraphic.com
ISSN 2007-6509 (Print)
Órgano oficial de la Asociación Mexicana de Medicina Transfusional A.C.

2011, Number 2

<< Back Next >>

Rev Mex Med Transfus 2011; 4 (2)

Donor selection

D´Artote GAL

Language: Spanish
References: 17
Page: 53-61
PDF size: 77.66 Kb.


ABSTRACT

In the blood bank procedures the donor selection process is a key element in transfusion safety chain, faces the challenge of assessing the health of the blood donor so as to ensure, as far as possible, that the act of giving will not have undesirable effects in the blood donor and does not represent a risk to the recipient. To achieve this objective selection criteria has to be reviewed periodically to adjust for the analysis of the causes of rejection and seroprevalence to infectious agents, preventing these criteria are so strict that could cause a high percentage of rejection that could jeopardize the blood supply. A review of the criteria for selection of disposing is done.


REFERENCES

  1. Eder A, Goldman M. Blood donor health and safety. USA, AABBPress, 2009.

  2. Eder A, Goldman M, Rossman S, Waxman D, Bianco C. Selection criteria to protect the blood donor in North America and Europe: Past (Dogma), present (Evidence), and future (Hemovigilance). Transfus Med Rev 2009; 23: 3: 205-220.

  3. Council of Europe Guide to the preparation, use and quality assurance of blood components 14th Ed. Strabourg Council of Europe; 2008.

  4. JOINT UKBTS/HPA Professional Advisory Committee Change Notification UK National Blood Services 7th Ed. Sheffield; 2011.

  5. Norma Oficial Mexicana NOM-003-SSA2-1993 para la Disposición de Sangre Humana y sus Componentes con Fines Terapéuticos, publicada en el Diario Oficial de la Federación en 1994.

  6. Roback J, Rae Coombs M, Grossman B, Hiller Ch. Technical Manual AABB Press Bethesda Maryland 2008.

  7. Newman B, Gedie J, Perkins J. The effect of beta blocker anti-hypertensive agents on whole blood donor reaction rates (abstract). Transfusion 1989; 29 (Suppl): 61S.

  8. Tomasulo PA, Anderson AJ, Paluso MB et el. A study of criteria for blood donor deferral. Transfusion 1980; 20: 511-8.

  9. Sauer LA, France CR. Caffeine attenuates vasovagal reactions in female first-time blood donors. Health Psychol 1999; 18: 403-9.

  10. Armstrong B, Hardwick J, Raman L, Smart E, Wilkinson R. Introduction to blood transfusion technology. Vox Sang 2008; 3: 6.

  11. Maslanka K, Marciniak-Bielak D, Szczepinski A. Pseudothrombocytopenia in blood donors Vox Sang 2008; 95: 349.

  12. Middelburg RA, Pocelijn L, Lardy N, Briet E, Vrielink H, Prevalence of leukocyte antibodies in the Dutch donor population. Vox Sang 2011; 100: 327-335.

  13. Blood Products Advisory Committee Meeting-Xenotropic Murine Leukemia or Virus Related Virus (XMRV): www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/BloodProductsAdvisoryCommitee/ucm18968.htm

  14. Malagón A, Guerra A, Pichardo-MJ, Gómez J. Rendimiento del escrutinio de la prueba de ácidos nucleicos (NAT) en donadores de sangre en la seguridad transfusional, (abstract). Revista Mexicana de Medicina Transfusional 2010; 3 (Supl 1): S118.

  15. Haimowitz MD, Eder A, Herron R, Dy B, Kennedy J M, Benjamin R. Medical evaluation of apheresis platelets donors with true positive bacterial cultures (abstract). Transfusion 2008; 48 (Suppl): S3-010A.

  16. WHO guidelines on good manufacturing practices for blood establishments. WHO Technical Report Series No 961, 2011.

  17. UKBTS Whole blood and component donor selection Guidelines Joint Professional Advisory Committee (JPAC) WB&C-DSG Edition 203, Release 04 Published 21 March 2011.




2020     |     www.medigraphic.com